Atrioventricular Septal Defect
3 clinical trials · Condition
◉ Watch Atrioventricular Septal Defect
| Record | Firm | Date |
|---|---|---|
| A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects (NCT05253209) | Asklepion Pharmaceuticals, LLC | 2022-06-29 |
| Aberrations in Carnitine Homeostasis in Congenital Heart Disease With Increased Pulmonary Blood Flow (NCT01825369) | University of California, San Francisco | 2014-12-01 |
| Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol (NCT01120964) | Asklepion Pharmaceuticals, LLC | 2010-09-01 |
Track Atrioventricular Septal Defect automatically
Every clearance here is in the API, with alerts when new ones post.